Laird Norton Trust Company, LLC Inmune Bio, Inc. Transaction History
Laird Norton Trust Company, LLC
- $582 Million
- Q3 2025
A detailed history of Laird Norton Trust Company, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 25,000 shares of INMB stock, worth $36,250. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,000
Previous 37,000
32.43%
Holding current value
$36,250
Previous $85,000
38.82%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding INMB
# of Institutions
85Shares Held
5.36MCall Options Held
310KPut Options Held
371K-
Vanguard Group Inc Valley Forge, PA876KShares$1.27 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.18 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$864,73945.87% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$680,6880.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$535,6850.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $26M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...